Nomination Committee for the Annual General Meeting 2027 in Stille

The nomination committee shall consist of a minimum of three members in total, excluding the chair of the board. The chair of the board shall also convene the first meeting of the nomination committee.

The chair of the board shall – no later than two weeks after the end of the third quarter of Stille’s financial year each year – ensure that the company’s three largest shareholders or shareholder groups are offered the opportunity to each appoint one member to serve on the nomination committee. The determination shall be based on Euroclear Sweden AB’s shareholder register (grouped by owner) as of the last banking day in September, or such other documentation as shareholders or shareholder groups at that time present as evidence of their shareholding.

At the end of the third quarter of 2026, the three largest shareholders in Stille were Impilo Surgical Products AB, Linc AB and Lannebo Kapitalförvaltning. They have appointed the following representatives:

• Fredrik Strömholm, on behalf of Impilo Surgical Products AB
• Thomas Bergh, on behalf of Linc AB
• Claes Murander, on behalf of Lannebo Kapitalförvaltning

The nomination committee shall prepare and submit the following proposals to the annual general meeting:

• election of chair of the annual general meeting
• election of the chair of the board and members of the company’s board of directors
• election of auditor and, where applicable, alternate auditor
• proposal on remuneration to the chair of the board, board members, auditor and, where applicable, committee work principles for the establishment of the nomination committee